DiaCarta Overview
- Year Founded
-
2012

- Status
-
Private
- Employees
-
39

- Latest Deal Type
-
Reverse Merger
- (Cancelled)
- Latest Deal Amount
-
$584M
- Investors
-
4
DiaCarta General Information
Description
Developer of detection tools designed for cancer diagnosis, therapy identification, and prognosis monitoring. The company's tools offer a range of cancer diagnostics and IVD products specialized in genomic testing for biomarkers and also offer clinical sample testing services apart from oncology along with COVID-19 testing services, enabling healthcare practitioners to provide improved care to patients.
Contact Information
Website
www.diacarta.comCorporate Office
- 4385 Hopyard Road
- Suite 100
- Pleasanton, CA 94588
- United States
Corporate Office
- 4385 Hopyard Road
- Suite 100
- Pleasanton, CA 94588
- United States
DiaCarta Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Reverse Merger | 13-Oct-2022 | $584M | Cancelled | Generating Revenue | ||
4. Debt - PPP | 14-May-2020 | Completed | Generating Revenue | |||
3. Grant | 17-Sep-2018 | Completed | Generating Revenue | |||
2. Early Stage VC (Series B) | 12-Feb-2018 | $45M | $53M | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | 09-Jan-2015 | $8M | $8M | Completed | Generating Revenue |
DiaCarta Comparisons
Industry
Financing
Details
DiaCarta Competitors (49)
One of DiaCarta’s 49 competitors is Ambry Genetics, a Formerly PE-Backed company based in Aliso Viejo, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
Igenomix | Formerly PE-Backed | Miami, FL | ||||
GeneCast Biotechnology | Private Equity-Backed | Wuxi, China | ||||
Biocept | Formerly VC-backed | San Diego, CA | ||||
Biodesix | Formerly VC-backed | Louisville, CO |
DiaCarta Patents
DiaCarta Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4136229-A1 | Sars-cov-2 test kit for rt-qpcr assays | Pending | 16-Apr-2020 | ||
CA-3175815-A1 | Sars-cov-2 test kit for rt-qpcr assays | Pending | 16-Apr-2020 | ||
EP-4136229-A4 | Sars-cov-2 test kit for rt-qpcr assays | Pending | 16-Apr-2020 | ||
EP-3494236-B1 | Method for conducting early detection of colon cancer and/or of colon cancer precursor cells and for monitoring colon cancer recurrence | Active | 05-Jan-2017 | ||
EP-3494236-A1 | Method for conducting early detection of colon cancer and/or of colon cancer precursor cells and for monitoring colon cancer recurrence | Active | 05-Jan-2017 | C12Q1/6886 |
DiaCarta Signals
DiaCarta Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
National Institutes of Health | Government | |||
Fortune Fountain Capital | PE/Buyout | Minority | ||
Global Healthcare Capital | Real Estate | Minority | ||
BVCF | Venture Capital | Minority |
DiaCarta Acquisitions (1)
DiaCarta’s most recent deal was a Merger/Acquisition with HH&L Acquisition for . The deal was made on 30-Jun-2023.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
HH&L Acquisition | 30-Jun-2023 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
DiaCarta FAQs
-
When was DiaCarta founded?
DiaCarta was founded in 2012.
-
Where is DiaCarta headquartered?
DiaCarta is headquartered in Pleasanton, CA.
-
What is the size of DiaCarta?
DiaCarta has 39 total employees.
-
What industry is DiaCarta in?
DiaCarta’s primary industry is Laboratory Services (Healthcare).
-
Is DiaCarta a private or public company?
DiaCarta is a Private company.
-
What is DiaCarta’s current revenue?
The current revenue for DiaCarta is
. -
How much funding has DiaCarta raised over time?
DiaCarta has raised $53M.
-
Who are DiaCarta’s investors?
National Institutes of Health, Fortune Fountain Capital, Global Healthcare Capital, and BVCF have invested in DiaCarta.
-
Who are DiaCarta’s competitors?
Ambry Genetics, Igenomix, GeneCast Biotechnology, Biocept, and Biodesix are some of the 49 competitors of DiaCarta.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »